Attached files
file | filename |
---|---|
8-K - FFO, AFFO & FAD RECONCILIATION - NATIONAL HEALTH INVESTORS INC | fforecast8-k.htm |
NATIONAL HEALTH INVESTORS, INC.
RECONCILIATION OF FUNDS FROM OPERATIONS, NORMALIZED FUNDS FROM OPERATIONS, ADJUSTED FUNDS FROM OPERATIONS, AND FUNDS AVAILABLE FOR DISTRIBUTION WITH AMOUNTS PREVIOUSLY REPORTED
(in thousands, except share and per share amounts)
Previously Reported | Currently Reported | ||||||
Year Ended | Year Ended | ||||||
December 31, 2012 | December 31, 2012 | ||||||
Net income attributable to common stockholders | $ | 90,731 | $ | 90,731 | |||
Elimination of certain non-cash items in net income: | |||||||
Real estate depreciation in continuing operations | 13,182 | 14,772 | |||||
Real estate depreciation related to noncontrolling interest | (68 | ) | (87 | ) | |||
Real estate depreciation in discontinued operations | 2,209 | 2,209 | |||||
Net gain on sales of real estate | (11,966 | ) | (11,966 | ) | |||
Funds from operations | $ | 94,088 | $ | 95,659 | |||
Investment gains | (4,760 | ) | (4,760 | ) | |||
Non-cash write-off of straight-line rent receivable | 963 | 963 | |||||
Expenses related to abandoned capital offering | 297 | 297 | |||||
Acquisition costs under business combination accounting | — | — | |||||
Legal settlement | 365 | 365 | |||||
Loan impairments (recoveries), net | (2,195 | ) | (2,195 | ) | |||
Other items, net | (271 | ) | (271 | ) | |||
Normalized FFO | $ | 88,487 | $ | 90,058 | |||
Straight-line lease revenue, net | (3,664 | ) | (3,664 | ) | |||
Amortization of debt issuance costs | 320 | ||||||
Non-cash write-off of straight-line rent receivable | (963 | ) | (963 | ) | |||
Normalized AFFO | $ | 83,860 | $ | 85,751 | |||
Non-real estate depreciation in continuing operations | 1,590 | — | |||||
Non-real estate depreciation related to noncontrolling interest | (19 | ) | — | ||||
Non-cash stock based compensation | 2,168 | 2,168 | |||||
Normalized FAD | $ | 87,599 | $ | 87,919 | |||
BASIC | |||||||
Weighted average common shares outstanding | 27,811,813 | 27,811,813 | |||||
FFO per common share | $ | 3.38 | $ | 3.44 | |||
Normalized FFO per common share | $ | 3.18 | $ | 3.24 | |||
Normalized AFFO per common share | $ | 3.02 | $ | 3.08 | |||
Normalized FAD per common share | $ | 3.15 | $ | 3.16 | |||
DILUTED | |||||||
Weighted average common shares outstanding | 27,838,720 | 27,838,720 | |||||
FFO per common share | $ | 3.38 | $ | 3.44 | |||
Normalized FFO per common share | $ | 3.18 | $ | 3.23 | |||
Normalized AFFO per common share | $ | 3.01 | $ | 3.08 | |||
Normalized FAD per common share | $ | 3.15 | $ | 3.16 |
NATIONAL HEALTH INVESTORS, INC.
RECONCILIATION OF FUNDS FROM OPERATIONS, NORMALIZED ADJUSTED FUNDS FROM OPERATIONS, AND NORMALIZED FUNDS AVAILABLE FOR DISTRIBUTION WITH AMOUNTS PREVIOUSLY REPORTED (CONTINUED)
(in thousands, except share and per share amounts)
Previously Reported For 2013 | Currently Reported For 2013 | ||||||||||||||
Three Months Ended | Three Months Ended | ||||||||||||||
June 30, | September 30, | June 30, | September 30, | ||||||||||||
Net income attributable to common stockholders | $ | 19,920 | $ | 42,744 | $ | 19,920 | $ | 42,744 | |||||||
Elimination of certain non-cash items in net income: | |||||||||||||||
Real estate depreciation in continuing operations | 3,985 | 5,079 | 4,558 | 5,732 | |||||||||||
Real estate depreciation related to noncontrolling interest | (68 | ) | (199 | ) | (87 | ) | (226 | ) | |||||||
Real estate depreciation in discontinued operations | — | — | — | — | |||||||||||
Net gain on sales of real estate | — | (19,370 | ) | — | (19,370 | ) | |||||||||
Funds from operations | $ | 23,837 | $ | 28,254 | $ | 24,391 | $ | 28,880 | |||||||
Debt issuance costs expensed due to credit facility modifications | 353 | — | 353 | — | |||||||||||
Acquisition costs under business combination accounting | 208 | — | 208 | — | |||||||||||
Loan impairments (recoveries), net | — | (2,061 | ) | — | (2,061 | ) | |||||||||
Normalized FFO | $ | 24,398 | $ | 26,193 | $ | 24,952 | $ | 26,819 | |||||||
Straight-line lease revenue, net | (1,413 | ) | (1,713 | ) | (1,413 | ) | (1,713 | ) | |||||||
Amortization of debt issuance costs | 404 | 110 | |||||||||||||
Normalized AFFO | $ | 23,943 | $ | 25,216 | |||||||||||
Non-real estate depreciation in continuing operations | 573 | 653 | — | — | |||||||||||
Non-real estate depreciation related to noncontrolling interest | (19 | ) | (27 | ) | — | — | |||||||||
Non-cash stock based compensation | 253 | 253 | 253 | 253 | |||||||||||
Normalized FAD | $ | 23,792 | $ | 25,359 | $ | 24,196 | $ | 25,469 | |||||||
BASIC | |||||||||||||||
Weighted average common shares outstanding | 27,876,176 | 27,876,176 | 27,876,176 | 27,876,176 | |||||||||||
FFO per common share | $ | .86 | $ | 1.01 | $ | .87 | $ | 1.04 | |||||||
Normalized FFO per common share | $ | .88 | $ | .94 | $ | .90 | $ | .96 | |||||||
Normalized AFFO per common share | $ | .86 | $ | .90 | |||||||||||
Normalized FAD per common share | $ | .85 | $ | .91 | $ | .87 | $ | .91 | |||||||
DILUTED | |||||||||||||||
Weighted average common shares outstanding | 27,913,727 | 27,905,545 | 27,913,727 | 27,905,545 | |||||||||||
FFO per common share | $ | .85 | $ | 1.01 | $ | .87 | $ | 1.03 | |||||||
Normalized FFO per common share | $ | .87 | $ | .94 | $ | .89 | $ | .96 | |||||||
Normalized AFFO per common share | $ | .86 | $ | .90 | |||||||||||
Normalized FAD per common share | $ | .85 | $ | .91 | $ | .87 | $ | .91 |
NATIONAL HEALTH INVESTORS, INC.
RECONCILIATION OF FUNDS FROM OPERATIONS, NORMALIZED ADJUSTED FUNDS FROM OPERATIONS, AND NORMALIZED FUNDS AVAILABLE FOR DISTRIBUTION WITH AMOUNTS PREVIOUSLY REPORTED (CONTINUED)
(in thousands, except share and per share amounts)
Previously Reported For 2013 | Currently Reported For 2013 | ||||||||||||||||||||||
Year To Date Period Ended | Year To Date Period Ended | ||||||||||||||||||||||
June 30, | September 30, | December 31, | June 30, | September 30, | December 31, | ||||||||||||||||||
Net income attributable to common stockholders | $ | 35,663 | $ | 78,408 | $ | 106,183 | $ | 35,663 | $ | 78,408 | $ | 106,183 | |||||||||||
Elimination of certain non-cash items in net income: | |||||||||||||||||||||||
Real estate depreciation in continuing operations | 7,868 | 12,947 | 17,646 | 8,973 | 14,705 | 20,101 | |||||||||||||||||
Real estate depreciation related to noncontrolling interest | (135 | ) | (334 | ) | (537 | ) | (175 | ) | (401 | ) | (634 | ) | |||||||||||
Real estate depreciation in discontinued operations | — | — | 557 | — | — | 557 | |||||||||||||||||
Net gain on sales of real estate | — | (19,370 | ) | (22,258 | ) | — | (19,370 | ) | (22,258 | ) | |||||||||||||
Funds from operations | $ | 43,396 | $ | 71,651 | $ | 101,591 | $ | 44,461 | $ | 73,342 | $ | 103,949 | |||||||||||
Investment gains | — | — | (3,256 | ) | — | — | (3,256 | ) | |||||||||||||||
Debt issuance costs expensed due to credit facility amendments | 353 | 353 | 416 | 353 | 353 | 416 | |||||||||||||||||
Acquisition costs under business combination accounting | 208 | 208 | 208 | 208 | 208 | 208 | |||||||||||||||||
Loan impairments (recoveries), net | 4,037 | 1,976 | 1,976 | 4,037 | 1,976 | 1,976 | |||||||||||||||||
Normalized FFO | $ | 47,994 | $ | 74,188 | $ | 100,935 | $ | 49,059 | $ | 75,879 | $ | 103,293 | |||||||||||
Straight-line lease revenue, net | (2,695 | ) | (4,408 | ) | (6,560 | ) | (2,695 | ) | (4,408 | ) | (6,560 | ) | |||||||||||
Straight-line lease revenue, net, related to noncontrolling interest | — | — | 55 | — | — | 55 | |||||||||||||||||
Amortization of debt issuance costs | 486 | 596 | 706 | ||||||||||||||||||||
Normalized AFFO | $ | 94,430 | $ | 46,850 | $ | 72,067 | $ | 97,494 | |||||||||||||||
Non-real estate depreciation in continuing operations | 1,105 | 1,758 | 2,455 | — | — | — | |||||||||||||||||
Non-real estate depreciation related to noncontrolling interest | (40 | ) | (67 | ) | (97 | ) | — | — | — | ||||||||||||||
Non-cash stock based compensation | 1,833 | 2,086 | 2,339 | 1,833 | 2,086 | 2,339 | |||||||||||||||||
Normalized FAD | $ | 48,197 | $ | 73,557 | $ | 99,127 | $ | 48,683 | $ | 74,153 | $ | 99,833 | |||||||||||
BASIC | |||||||||||||||||||||||
Weighted average common shares outstanding | 27,871,120 | 27,872,805 | 28,362,398 | 27,871,120 | 27,872,805 | 28,362,398 | |||||||||||||||||
FFO per common share | $ | 1.56 | $ | 2.57 | $ | 3.58 | $ | 1.60 | $ | 2.63 | $ | 3.67 | |||||||||||
Normalized FFO per common share | $ | 1.72 | $ | 2.66 | $ | 3.56 | $ | 1.76 | $ | 2.72 | $ | 3.64 | |||||||||||
Normalized AFFO per common share | $ | 3.33 | $ | 1.68 | $ | 2.59 | $ | 3.44 | |||||||||||||||
Normalized FAD per common share | $ | 1.73 | $ | 2.64 | $ | 3.50 | $ | 1.75 | $ | 2.66 | $ | 3.52 | |||||||||||
DILUTED | |||||||||||||||||||||||
Weighted average common shares outstanding | 27,907,600 | 27,906,914 | 28,397,702 | 27,907,600 | 27,906,914 | 28,397,702 | |||||||||||||||||
FFO per common share | $ | 1.55 | $ | 2.57 | $ | 3.58 | $ | 1.59 | $ | 2.63 | $ | 3.66 | |||||||||||
Normalized FFO per common share | $ | 1.72 | $ | 2.66 | $ | 3.55 | $ | 1.76 | $ | 2.72 | $ | 3.64 | |||||||||||
Normalized AFFO per common share | $ | 3.33 | $ | 1.68 | $ | 2.58 | $ | 3.43 | |||||||||||||||
Normalized FAD per common share | $ | 1.73 | $ | 2.64 | $ | 3.49 | $ | 1.74 | $ | 2.66 | $ | 3.52 |